Therapeutic targeting of HYPDH/PRODH2 with N-propargylglycine offers a Hyperoxaluria treatment opportunity.
Biochim Biophys Acta Mol Basis Dis.
2024 Jan;1870(1):166848. doi: 10.1016/j.bbadis.2023.166848. Epub 2023 Aug 14. PubMed PMID:
37586438; PubMed Central PMCID:
PMC10854995.
N-Propargylglycine: a unique suicide inhibitor of proline dehydrogenase with anticancer activity and brain-enhancing mitohormesis properties.
Amino Acids.
2021 Dec;53(12):1927-1939. doi: 10.1007/s00726-021-03012-9. Epub 2021 Jun 5. PubMed PMID:
34089390; PubMed Central PMCID:
PMC8643368.
Altered germline cyst formation and oogenesis in Tex14 mutant mice.
Biol Open.
2021 Jun 15;10(6). doi: 10.1242/bio.058807. Epub 2021 Jun 22. PubMed PMID:
34156079; PubMed Central PMCID:
PMC8249907.
Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway.
Cell Rep.
2021 Feb 23;34(8):108784. doi: 10.1016/j.celrep.2021.108784. PubMed PMID:
33626341; PubMed Central PMCID:
PMC8608252.
A risk-associated Active transcriptome phenotype expressed by histologically normal human breast tissue and linked to a pro-tumorigenic adipocyte population.
Breast Cancer Res.
2020 Jul 31;22(1):81. doi: 10.1186/s13058-020-01322-6. PubMed PMID:
32736587; PubMed Central PMCID:
PMC7395362.
Pregnancy Hypertension and a Commonly Inherited IGF1R Variant (rs2016347) Reduce Breast Cancer Risk by Enhancing Mammary Gland Involution.
J Oncol.
2019;2019:6018432. doi: 10.1155/2019/6018432. eCollection 2019. PubMed PMID:
31687025; PubMed Central PMCID:
PMC6800903.
Integrative Molecular Characterization of Malignant Pleural Mesothelioma.
Cancer Discov.
2018 Dec;8(12):1548-1565. doi: 10.1158/2159-8290.CD-18-0804. Epub 2018 Oct 15. PubMed PMID:
30322867; PubMed Central PMCID:
PMC6310008.
Integrated Molecular Characterization of Testicular Germ Cell Tumors.
Cell Rep.
2018 Jun 12;23(11):3392-3406. doi: 10.1016/j.celrep.2018.05.039. PubMed PMID:
29898407; PubMed Central PMCID:
PMC6075738.
The Immune Landscape of Cancer.
Immunity.
2018 Apr 17;48(4):812-830.e14. doi: 10.1016/j.immuni.2018.03.023. Epub 2018 Apr 5. PubMed PMID:
29628290; PubMed Central PMCID:
PMC5982584.
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Cell.
2018 Apr 5;173(2):291-304.e6. doi: 10.1016/j.cell.2018.03.022. PubMed PMID:
29625048; PubMed Central PMCID:
PMC5957518.
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.
Cell Rep.
2018 Apr 3;23(1):194-212.e6. doi: 10.1016/j.celrep.2018.03.063. PubMed PMID:
29617660; PubMed Central PMCID:
PMC6002769.
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
Cell Rep.
2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075. PubMed PMID:
29617669; PubMed Central PMCID:
PMC6075733.
Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images.
Cell Rep.
2018 Apr 3;23(1):181-193.e7. doi: 10.1016/j.celrep.2018.03.086. PubMed PMID:
29617659; PubMed Central PMCID:
PMC5943714.
Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types.
Cell Rep.
2018 Apr 3;23(1):282-296.e4. doi: 10.1016/j.celrep.2018.01.088. PubMed PMID:
29617667; PubMed Central PMCID:
PMC5933844.
Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
JAMA Oncol.
2017 Dec 1;3(12):1654-1662. doi: 10.1001/jamaoncol.2017.0595. PubMed PMID:
28472234; PubMed Central PMCID:
PMC5671371.
Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.
Cell.
2017 Nov 2;171(4):950-965.e28. doi: 10.1016/j.cell.2017.10.014. PubMed PMID:
29100075; PubMed Central PMCID:
PMC5693358.
Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades.
JAMA Oncol.
2017 Nov 1;3(11):1503-1510. doi: 10.1001/jamaoncol.2017.1261. PubMed PMID:
28662222; PubMed Central PMCID:
PMC5710197.
ERpS294 is a biomarker of ligand or mutational ERα activation and a breast cancer target for CDK2 inhibition.
Oncotarget.
2017 Oct 13;8(48):83432-83445. doi: 10.18632/oncotarget.12735. eCollection 2017 Oct 13. PubMed PMID:
29137354; PubMed Central PMCID:
PMC5663526.
Functional IGF1R variant predicts breast cancer risk in women with preeclampsia in California Teachers Study.
Cancer Causes Control.
2017 Oct;28(10):1027-1032. doi: 10.1007/s10552-017-0942-7. Epub 2017 Aug 18. PubMed PMID:
28822014; PubMed Central PMCID:
PMC5613056.
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.
Cancer Cell.
2017 Aug 14;32(2):204-220.e15. doi: 10.1016/j.ccell.2017.07.003. PubMed PMID:
28810145; PubMed Central PMCID:
PMC5619925.
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.
Cell Rep.
2017 Jun 27;19(13):2878-2880. doi: 10.1016/j.celrep.2017.06.008. PubMed PMID:
28658632; PubMed Central PMCID:
PMC6141445.
Integrated genomic and molecular characterization of cervical cancer.
Nature.
2017 Mar 16;543(7645):378-384. doi: 10.1038/nature21386. Epub 2017 Jan 23. PubMed PMID:
28112728; PubMed Central PMCID:
PMC5354998.
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.
Cancer Cell.
2017 Feb 13;31(2):181-193. doi: 10.1016/j.ccell.2017.01.001. Epub 2017 Feb 2. PubMed PMID:
28162975; PubMed Central PMCID:
PMC5643159.
Comprehensive comparison of breast cancer molecular portraits by African and European ancestry in The Cancer Genome Atlas.
JAMA oncology. 2017 February; 77(4). doi: DOI: 10.1158/1538-7445.
Integrated genomic characterization of oesophageal carcinoma.
Nature.
2017 Jan 12;541(7636):169-175. doi: 10.1038/nature20805. Epub 2017 Jan 4. PubMed PMID:
28052061; PubMed Central PMCID:
PMC5651175.
TNF-α modulates genome-wide redistribution of ΔNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer.
Oncogene.
2016 Nov 3;35(44):5781-5794. doi: 10.1038/onc.2016.112. Epub 2016 May 2. PubMed PMID:
27132513; PubMed Central PMCID:
PMC5093089.
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.
Cancer Cell.
2016 Aug 8;30(2):363. doi: 10.1016/j.ccell.2016.07.013. Epub 2016 Aug 8. PubMed PMID:
27505681.
Adaptive Randomization of Neratinib in Early Breast Cancer.
N Engl J Med.
2016 Jul 7;375(1):11-22. doi: 10.1056/NEJMoa1513750. PubMed PMID:
27406346; PubMed Central PMCID:
PMC5259558.
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
N Engl J Med.
2016 Jul 7;375(1):23-34. doi: 10.1056/NEJMoa1513749. PubMed PMID:
27406347; PubMed Central PMCID:
PMC5259561.
Comment on: 'Hypertensive diseases in pregnancy and breast cancer risk'.
Br J Cancer.
2016 May 24;114(11):e10. doi: 10.1038/bjc.2016.81. Epub 2016 May 3. PubMed PMID:
27140311; PubMed Central PMCID:
PMC4891511.
DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome Atlas.
NPJ Breast Cancer.
2016;2:16007. doi: 10.1038/npjbcancer.2016.7. eCollection 2016. PubMed PMID:
28721375; PubMed Central PMCID:
PMC5515343.
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.
Cell.
2016 Jan 28;164(3):550-63. doi: 10.1016/j.cell.2015.12.028. PubMed PMID:
26824661; PubMed Central PMCID:
PMC4754110.
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.
N Engl J Med.
2016 Jan 14;374(2):135-45. doi: 10.1056/NEJMoa1505917. Epub 2015 Nov 4. PubMed PMID:
26536169; PubMed Central PMCID:
PMC4775252.
The Molecular Taxonomy of Primary Prostate Cancer.
Cell.
2015 Nov 5;163(4):1011-25. doi: 10.1016/j.cell.2015.10.025. PubMed PMID:
26544944; PubMed Central PMCID:
PMC4695400.
FOXM1 cistrome predicts breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index.
Breast Cancer Res Treat.
2015 Nov;154(1):23-32. doi: 10.1007/s10549-015-3589-7. Epub 2015 Oct 12. PubMed PMID:
26456572.
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.
Cell.
2015 Oct 8;163(2):506-19. doi: 10.1016/j.cell.2015.09.033. PubMed PMID:
26451490; PubMed Central PMCID:
PMC4603750.
MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation.
Nat Cell Biol.
2015 Aug;17(8):1049-61. doi: 10.1038/ncb3195. Epub 2015 Jul 6. PubMed PMID:
26147250; PubMed Central PMCID:
PMC4691706.
The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer.
Clin Cancer Res.
2015 Jul 1;21(13):2911-5. doi: 10.1158/1078-0432.CCR-14-1760. Epub 2015 Feb 24. PubMed PMID:
25712686; PubMed Central PMCID:
PMC4490043.
Genomic Classification of Cutaneous Melanoma.
Cell.
2015 Jun 18;161(7):1681-96. doi: 10.1016/j.cell.2015.05.044. PubMed PMID:
26091043; PubMed Central PMCID:
PMC4580370.
First Pregnancy Characteristics, Postmenopausal Breast Density, and Salivary Sex Hormone Levels in a Population at High Risk for Breast Cancer.
BBA Clin.
2015 Jun;3:189-195. doi: 10.1016/j.bbacli.2015.02.003. PubMed PMID:
26317068; PubMed Central PMCID:
PMC4547694.
A steroid metabolizing gene variant in a polyfactorial model improves risk prediction in a high incidence breast cancer population.
BBA Clin.
2014 Dec;2:94-102. doi: 10.1016/j.bbacli.2014.11.001. eCollection 2014 Dec. PubMed PMID:
26673457; PubMed Central PMCID:
PMC4633888.
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature.
2014 Sep 11;513(7517):202-9. doi: 10.1038/nature13480. Epub 2014 Jul 23. PubMed PMID:
25079317; PubMed Central PMCID:
PMC4170219.
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.
Cell.
2014 Aug 14;158(4):929-944. doi: 10.1016/j.cell.2014.06.049. Epub 2014 Aug 7. PubMed PMID:
25109877; PubMed Central PMCID:
PMC4152462.
Comprehensive molecular profiling of lung adenocarcinoma.
Nature.
2014 Jul 31;511(7511):543-50. doi: 10.1038/nature13385. Epub 2014 Jul 9. PubMed PMID:
25079552; PubMed Central PMCID:
PMC4231481.
Sources of superoxide/H2O2 during mitochondrial proline oxidation.
Redox Biol.
2014;2:901-9. doi: 10.1016/j.redox.2014.07.003. eCollection 2014. PubMed PMID:
25184115; PubMed Central PMCID:
PMC4143814.
RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth.
Oncotarget.
2014 Jul 15;5(13):5165-76. doi: 10.18632/oncotarget.2099. PubMed PMID:
24970821; PubMed Central PMCID:
PMC4148130.
First pregnancy events and future breast density: modification by age at first pregnancy and specific VEGF and IGF1R gene variants.
Cancer Causes Control.
2014 Jul;25(7):859-68. doi: 10.1007/s10552-014-0386-2. Epub 2014 May 7. PubMed PMID:
24801045; PubMed Central PMCID:
PMC4048469.
mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms.
Breast Cancer Res Treat.
2014 Apr;144(2):287-298. doi: 10.1007/s10549-014-2877-y. Epub 2014 Feb 22. PubMed PMID:
24562770; PubMed Central PMCID:
PMC4318538.
Phosphoprotein secretome of tumor cells as a source of candidates for breast cancer biomarkers in plasma.
Mol Cell Proteomics.
2014 Apr;13(4):1034-49. doi: 10.1074/mcp.M113.035485. Epub 2014 Feb 6. PubMed PMID:
24505115; PubMed Central PMCID:
PMC3977182.
Comprehensive molecular characterization of urothelial bladder carcinoma.
Nature.
2014 Mar 20;507(7492):315-22. doi: 10.1038/nature12965. Epub 2014 Jan 29. PubMed PMID:
24476821; PubMed Central PMCID:
PMC3962515.
What would you like to do?